Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND)

详细信息    查看全文

• 作者：Oreste Gentilini ; Umberto Veronesi
• 关键词：Sentinel lymph node biopsy (SLNB) ; Breast cancer treatment ; Ultra-sound ; Axillary surgery
• 刊名：The Breast
• 出版年：2012
• 出版时间：October, 2012
• 年：2012
• 卷：21
• 期：5
• 页码：678-681
• 全文大小：336 K

文摘

| Figures/TablesFigures/Tables | ReferencesReferences

Viewpoints and debates

Sentinel lymph node biopsy (SLNB) is the standard approach for axillary staging in patients with early breast cancer. Recent data showed no outcome difference in patients with positive sentinel node between axillary dissection vs no further axillary surgery, raising doubts on the role of SLNB itself. Therefore, a new trial was designed comparing SLNB vs observation when axillary ultra-sound is negative in patients with small breast cancer candidates to breast conserving surgery.